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1.   Introduction 
Many studies in the social and epidemiological  sciences aim to make causal inferences using 
observational data. This is often problematic, as it is not always clear which of any two associated 
variables is the cause and which is the effect, or whether other unobserved factors affect both 
variables. Randomization of treatment, like that in a Randomized Controlled Trial (RCT), is one way 
to infer causality. However, such experiments are not always possible or feasible. 
To deal with issues of reverse causation and unobserved residual  confounding, an approach 
commonly used in the economics and econometrics literature is that of Instrumental Variables (IV). 
This approach introduces a third variable (the instrument) that (partly) determines the level of the 
treatment or exposure of interest, but does not have a direct or indirect effect on the outcome 
variable, other than through its effect on treatment. This instrument can then be exploited to make 
causal inferences about the effect of the variable of interest on different outcomes. 
‘Mendelian randomization’ refers to the random assignment of an individual’s genotype at 
conception (Davey Smith and Ebrahim, 2003). Under certain assumptions that we discuss in detail 
below, observed associations between genetic variants and the outcome of interest cannot be due 
to reverse causation or confounding by behavioural or environmental factors, including those that 
occur  in utero. Mendelian randomization can therefore be exploited to make causal inferences 
about the effects of modifiable (non-genetic) risk factors, on different outcomes (see Appendix A for 
a brief guide to the terms used in genetic studies). 
Mendelian randomization is receiving  increasing attention from epidemiologists,  statisticians, 
economists  and social scientists.  Statisticians have highlighted some of the implicit statistical 
assumptions commonly made in Mendelian randomization studies (e.g. Didelez and Sheehan, 2007; 
Didelez, Meng, and Sheehan, 2010). Studies in genetic epidemiology on the other hand, emphasize 
the importance of carefully examining the conditions that need to be met for genetic variants to be 
used as instruments (see e.g. Davey Smith and Ebrahim, 2003; Sheehan et al. 2008; Lawlor et al., 
2008). These conditions, however, have not been disseminated widely in the economics and social 
science literature, but the increasing availability of biomedical information in social science datasets 
makes understanding them crucial to the successful use of genotypes as instruments for modifiable 
risk factors. The main contribution of this paper therefore, is to discuss the conditions as defined in 
the epidemiology literature and relate them to the IV assumptions as used in statistics and 
economics. We do this using the potential outcomes framework, building on the work by Imbens 
and Angrist (1994) and Angrist, Imbens and Rubin (1996), which has been of great importance in 
linking the econometric IV literature to the potential outcomes framework. Note, however, that   2 
instrumental variables have also been defined using different approaches to causal inference, 
including causal Directed Acyclic Graphs (DAGs) and structural equation models (see Hernàn and 
Robins (2006) for an overview and comparison). 
To clearly communicate best practice in genetic epidemiology to a wider social science audience, we 
review these conditions in the context of an empirical social science application. Specifically, we 
examine whether child adiposity (fat mass) causally affects academic achievement, using recently 
identified genetic variants as instrumental variables for adiposity.  
We select this example for the following reasons. A causal effect of adiposity on academic 
achievement may run via various pathways. For example, obese children are more likely to be 
absent from school, to have sleep disorders, and be treated differently by teachers, parents and 
peers. All of these may affect children’s (learning) environment and educational outcomes. 
However, an observed association between adiposity and academic achievement is not necessarily 
causal. It could, for example, be driven by children changing their eating habits in response to poor 
school results. In addition, one can never be sure that all relevant confounders are accounted for. In 
other words, the association may be driven by other unobserved factors relating to both weight and 
academic outcomes.  
We attempt to deal with this possible reverse causation and unobserved confounding using 
Mendelian randomization, aiming  to identify the causal effect of adiposity on academic 
achievement. When using carefully selected genetic variants as instrumental variables for adiposity, 
we find no evidence of a causal relationship between adiposity and academic performance, although 
the parameters are imprecisely estimated. In contrast, the use of ordinary least squares (OLS) leads 
to inferences of an inverse association.  
The next section presents our statistical framework, details the conditions that need to be met for 
genetic variants to be used as instruments, presents our choice of genetic variants and contrasts this 
with the existing literature. Section three introduces the data. The results are presented in section 
four; section five concludes and discusses the implications of our findings.  
 
2.   The Use of Genetic Variants as Instrumental Variables 
2.1   The Potential Outcomes Framework 
Let 𝑆, 𝐴 and 𝑍 denote random variables representing, respectively, the educational outcome, the 
adiposity measure and the (for now: binary) genetic variant as instrumental variable. 𝑍𝑖 = 1 
indicates that individual 𝑖 carries the genetic variant, 𝑍𝑖 = 0 implies that individual 𝑖 does not carry   3 
the genetic variant.  
Let 𝐴𝑖(𝑧) be the potential adiposity for individual 𝑖 when the instrument is set to 𝑧. As with all 
potential outcomes, only one of the treatment assignments is ever observed for any one individual. 
Hence, we either observe 𝑖’s adiposity when 𝑖 does not carry the risk allele, 𝐴𝑖(0), or we observe 𝑖’s 
adiposity when 𝑖 does carry the risk allele, 𝐴𝑖(1). Similarly, let 𝑆𝑖(𝑎,𝑧) be the potential outcome for 
individual 𝑖 that would be obtained if the adiposity, the treatment variable, was set to 𝑎 and the 
instrument set to 𝑧  by external intervention. We refer to 𝐴𝑖(𝑧)  and  𝑆𝑖(𝑎,𝑧)  as the potential 
treatments and potential outcomes respectively.  
The individual treatment effect, or causal effect, is 𝑆𝑖(𝑎′,𝑧) − 𝑆𝑖(𝑎,𝑧), where 𝑎 is some baseline 
value. Under the exclusion restriction discussed below, we can write 𝑆𝑖(𝑎′,𝑧) = 𝑆𝑖(𝑎′). Our causal 
estimand of interest can therefore be written as: 
 
          𝐸[𝑆𝑖(𝑎′) − 𝑆𝑖(𝑎)].          (1) 
 
Hernàn and Robins (2006) outline the assumptions under which this causal effect is identified by the 
simple IV estimator that we use. These include linearity of the causal effect of 𝐴 on 𝑆 and no effect 
modification of the instrument on the treatment effect. Angrist, Graddy and Imbens (2000) however, 
specify the conditions under which the simple IV estimator identifies a weighted average of the 
derivative function of the (nonlinear) causal response function, exploiting a monotonicity 
assumption of the effect of the instrument on the exposure. We discuss these assumptions in turn. 
 
Assumption 1. (Stable Unit Treatment Value Assumption, or SUTVA). 
SUTVA implies that individual 𝑖’s potential treatment is unrelated to the instrument values of other 
individuals, and that individual  𝑖’s  potential  outcomes are unrelated to the treatment and 
instrument values of other individuals. In other words, there is no interference between units. 
 
Assumption 2. (Independence). 
𝑍𝑖 ⊥ {𝑆𝑖(𝑎,𝑧),𝐴𝑖(𝑧)}𝑎,𝑧  
 
The independence assumption implies that the instrument is independent of all potential outcomes 
and potential treatments, for all values of 𝑎 and 𝑧. In other words, the instrument is as good as   4 
randomly assigned.  
 
Assumption 3. (Exclusion). 
𝑆𝑖(𝑎,1) = 𝑆𝑖(𝑎,0), for all 𝑎. 
 
Exclusion implies that the potential outcomes, at any level of adiposity 𝑎, are unchanged by the 
presence or absence of the genetic variant. In other words, the only way through which the 
instrument affects the potential outcome is via 𝐴.  Exclusion is distinct from the independence 
assumption, in that it is a claim about a unique channel of the causal effect of the instrument. It 
implies that 𝑆𝑖(𝑎,𝑧) is a function of 𝑎 only, and hence we can write 𝑆𝑖(𝑎,𝑧) = 𝑆𝑖(𝑎), as used in (1). 
 
Assumption 4. (Non-zero effect of instrument on treatment). 
 
𝐸[𝐴𝑖(1) − 𝐴𝑖(0)] ≠ 0 
 
This implies that expected potential adiposity is affected by the genetic variant and therefore that 
the instrument has an effect on the treatment. 
 
Assumption 5. (Monotonicity). 
𝑃[𝐴𝑖(1) ≥ 𝐴𝑖(0)] = 1, for all 𝑖 
 
(or vice versa), saying that the potential treatment (i.e. adiposity) for individual 𝑖 with the genetic 
variant is at least as high as the potential treatment for the same individual without the genetic 
variant for all 𝑖. In other words, all those affected by the instrument are affected in the same way. 
 
In the presence of heterogeneous responses, the potential outcome for individual 𝑖 can be written 
as a general function of 𝑎, say 𝑆𝑖(𝑎) ≡ 𝑔𝑖(𝑎). We use assumptions 1 to 5 to interpret differences in 
average outcomes and treatments at different values of the instrument. Under these assumptions, 
the instrumental variables estimand, defined as the ratio of the difference in average outcomes at 
two values of the instrument to the difference in average treatment at the same two values of the 
instrument, can be written as:  
𝐸[𝑆𝑖|𝑍𝑖 = 1] − 𝐸[𝑆𝑖|𝑍𝑖 = 0]
𝐸[𝐴𝑖|𝑍𝑖 = 1] − 𝐸[𝐴𝑖|𝑍𝑖 = 0]
   5 




,  (2) 
 
where 𝑔𝑖
′(𝑞) is the derivative of 𝑔𝑖(𝑎) w.r.t. 𝑎 evaluated at 𝑞. Hence, the IV estimand is a weighted 
average of the derivative function (Angrist, Graddy and Imbens, 2000; Angrist and Pischke, 2009).  
In our application, the IV (Wald) estimand in (2) can be interpreted as the effect of adiposity on 
educational attainment for those whose adiposity is affected by the genetic instrument. This specific 
group is also referred to as the compliers: those who are induced to take treatment by assignment to 
treatment. In addition to these compliers, three further (latent) groups have been defined: those 
who do the opposite of their assignment (defiers), those who never take treatment, whatever their 
assignment (never-takers), and those who always take treatment, regardless of their assignment 
(always-takers). This stratification into latent groups is commonly used in the econometrics 
literature (see e.g. Angrist, Imbens and Rubin, 1996). Frangakis and Rubin (2002) have generalised 
this  concept  to any type of post-treatment variable within the potential outcomes framework, 
known as ‘principal stratification’. Principal stratification has two important properties: (1) the strata 
(in this case: compliers, defiers, always-takers and never-takers) are not affected by the assigned 
treatment, and (2) comparisons of potential outcomes under different assignments within principal 
strata, also called principal effects, are well-defined causal effects. Hence, principal stratification can 
be seen as an extension of the IV methodology used here (see e.g. Barnard et al. (2003) for an 
application of principal stratification to a ‘broken’ randomized experiment, and Shinohara et al. 
(2009) and Shinohara and Frangakis (2009) for a comparison of principal stratification and IV in case-
control studies).  
The above discussion uses a binary instrument throughout. In our application however, we have 
multiple and multi-valued instruments. In the case of such discrete instruments, the number of 
instruments is irrelevant; it is the number of distinct values of the instrument vector that matters, 
averaging the (pairwise) instrument-specific weighted averages of the derivative function (Angrist, 
Graddy and Imbens, 2000).  
 
2.2   Mendelian Randomization 
We discuss the use of Mendelian randomization from a statistics and economics perspective in the 
context of a social study, with the aim of making causal inferences of the effect of a modifiable risk 
factor on an outcome of interest. As opposed to observational studies that estimate the effect of 
short term (current) differences in exposure, estimates from Mendelian randomization experiments   6 
reflect lifetime differences in exposure. Hence, they indicate the long term (cumulative) effects of 
the modifiable risk factor on the outcome of interest (Davey Smith and Ebrahim, 2005).  
The concept of Mendelian randomization is closely linked to Randomised Controlled Trials (RCTs), 
where the allocation of treatment is randomised over all eligible individuals. Indeed, the 
instrumental variable methodology can be applied to analyse encouragement designs (such as RCTs 
where the treatment is the encouragement to participate) that are affected by non-ignorable non-
compliance. Non-compliance refers to the fact that individuals can choose treatments other than 
those to which they are randomised. Non-ignorable non-compliance refers to participants choosing 
treatment in a manner associated with their study outcomes, after adjusting for baseline 
characteristics. This is also known as endogenous treatment in economics, or  selection into 
treatment. 
The idea is similar for the social context in our application: individuals ‘select’ their treatment – 
adiposity – through lifestyle choices, such as diet and physical activity. Even after adjusting for 
baseline characteristics, these choices are likely to be related to their study outcome (educational 
attainment). In other words, they are non-ignorable. Mendelian randomization exploits the fact that 
there is an equal probability that either parental allele is transmitted to offspring. Whilst this 
allocation is random at the family trio level, at a population level it has been demonstrated that 
genetic variants are largely unrelated to the many socioeconomic and behavioural characteristics 
that are closely linked with each other and that confound conventional observational studies (Bhatti 
et al., 2005; Davey Smith et al., 2008; Kivimäki et al., 2008; Lawlor et al., 2008; see also Fisher, 1952 
and Box  2010).  Hence, as genes  are  randomly assigned during meiosis, individuals of different 
genotypes are expected not to differ systematically in any other respect.  
We use Mendelian randomization and IV in the context of an empirical social science application. 
Although IV methods are widely used in statistics and economics, the use of genetic variants in these 
fields is relatively new. As noted by Didelez and Sheehan (2007), the potential limitations of 
Mendelian randomization experiments can be represented in two main categories. First, limitations 
related to the implicit statistical assumptions common in many Mendelian randomization studies 
(see  e.g. Didelez and Sheehan (2007) and Didelez, Meng, and Sheehan  (2010) for a thorough 
discussion). Second, potential limitations relating to the assumptions of the validity of the 
instrument. Genetic epidemiology studies mainly emphasize the latter: the importance of carefully 
examining several situations and (biological) processes that may violate the assumptions mentioned 
in section 2.1 (see e.g. Davey Smith and Ebrahim, 2003; Sheehan, et al. 2008; Lawlor et al., 2008). 
The existing research in economics however, has mainly failed to recognise these. But the increasing 
availability of biomedical  information in social science datasets makes understanding of these   7 
conditions crucial to the successful use of genotypes as instruments for modifiable risk factors. We 
therefore discuss the concepts defined in epidemiology and relate them to the assumptions that 
need to be met to obtain causal estimates of the effect of the risk factor on the outcome of interest, 
as defined in the statistics and economics literature.  
 
2.3   Conditions for the Use of Genetic Variants as Instrumental Variables 
For a valid causal interpretation of the IV (Wald) estimand, we require assumptions 1 to 5 in section 
2.1 to hold. Although we believe these assumptions are plausible, there are various situations that 
may violate them, and therefore need to be examined.  
 
Assumption 1 – SUTVA  
The potential treatment of any individual is not affected by the genetic variants of other individuals. 
Similarly, the potential outcome of any individual is not affected by the genetic variant or treatment 
of other individuals. The assumption of no interference between units is conventional in statistics 
and medical research, but the existence of peer effects may invalidate this. However, as peer effects 
are more likely to be due to (unobserved) behaviour than genes, this is less likely to be a problem 
here.  
 
Assumption 2 – Independence 
Although genotypes are randomly allocated at conception, the allele distribution may differ for 
different population subgroups. If these subgroups also have systematically different outcomes of 
interest, this could lead to an association between the two at the population level without an actual 
causal relationship. A systematic relationship between the allele frequency and the outcome of 
interest across different sub-populations is also referred to as population stratification. For example, 
allele frequencies can vary across ethnic groups. Any systematic differences in educational outcomes 
across these subpopulations that are not due to a genetic make-up may therefore lead to biased 
estimates of the effect of adiposity by violating the independence Assumption 2. In other words, 
despite the fact that genotypes are randomly allocated and with that satisfy the independence 
assumption,  any  population stratification can violate  this assumption. This can be dealt with 
however, by examining the question of interest within  ethnic groups,  separately analyzing the 
different sub-populations, and/or adjusting for principal components from genome wide data that 
function as ancestry markers, relying on the conditional independence assumption.    8 
As genotypes are randomly assigned given the parental genes, the presence of assortative mating 
based on genes can violate the independence assumption. The cleanest experiment, therefore, is 
one with biological siblings, examining randomization of genes within families (Davey Smith and 
Ebrahim,  2003). However, even when we only observe one individual per family, Mendelian 
randomization is valid assuming that, at the population level, genetic variants are unrelated to other 
characteristics, as has been shown in many studies (Bhatti et al., 2005; Davey Smith et al., 2008; 
Kivimäki et al., 2008; Lawlor et al., 2008; see also Fisher, 1952; Box 2011). One way to indirectly test 
independence is by exploring whether the distribution of individual or family-level characteristics 
that are available in the data is the same in different groups defined by the value of the instrument 
(i.e. different genotypes). The idea is that, if the instrumental variable is indeed randomized, there 
should be no systematic variation in the covariates by genotype, whether we use a within-  or 
between-family analysis. This raises the question however, about which covariates to test for, as any 
characteristic is, in principle, a post-treatment variable with respect to the instrument. Hence, any 
systematic variation in these indirect tests does not necessarily indicate a violation of independence 
(or exclusion). It may be, for example, that the instrument is picking up additional causal effects of 
the same risk factor, or that it is picking up reverse causation from the outcome to a different 
covariate. 
 
Assumption 3 – Exclusion  
There can, in principle, be various situations in which Assumption 3 – the exclusion restriction – does 
not hold, invalidating the instruments. A first situation is that ‘behaviours’ may be affected by the 
genotype. As individuals inherit their genes from their parents, it may be important to consider 
whether parents’ behaviours or preferences are affected by their genotype  (and hence their 
offspring’s genotype). This may be a problem in studies that examine maternal behaviours that 
influence the outcome of interest via intrauterine effects, or in studies where parental behaviours 
influence the outcome of interest via affecting their (child’s) behaviour. For example, if one were 
interested in the effect of an individual’s alcohol consumption on their later liver disease using a 
genetic variant that robustly relates to alcohol intake, any intrauterine effects of maternal alcohol 
consumption  during  pregnancy  on  offspring liver development could result in a violation of 
Assumption 3. This is because the mother’s genotype is related to the offspring’s genotype (the 
instrument), and will influence her alcohol consumption throughout life, including when she was 
pregnant. If maternal prenatal alcohol intake affects liver development in utero and its functioning 
later in the child’s life, there is a link from the offspring’s genotype (IV) to the outcome via an 
intrauterine mechanism. Similarly, if one is interested in the effect of adiposity (fat) on education, as   9 
we are below, parents who carry ‘fat’ alleles may be discriminated against in the labour market 
because of their higher weights. If this affects their  behaviour  or preferences for her child’s 
education, Assumption 3 may be violated. The extent of this potential violation will depend on the 
effect sizes of the variants. In other words, if the variants shift the fat mass distribution by a modest 
amount, it may be unlikely to lead to strong (parental) responses. 
A second situation relates to the mechanisms through which genetic variants affect the modifiable 
risk factor. These are often unknown. If the mechanism involves changes in behaviour or preferences 
that in addition to affecting the treatment also directly affect the outcome, Assumption 3 will be 
violated. If the mechanism only results in changes to the risk factor (i.e. they do not directly affect 
the outcome), Assumption 3 will not be violated. 
Thirdly, the genetic instrument may be related to other genetic variants that affect the outcome of 
interest. Mendel’s second law states that the inheritance of one trait is independent of the 
inheritance of another. However, it has been shown that this does not always hold and that some 
variants are likely to be co-inherited. This so-called ‘Linkage Disequilibrium’ (LD) does not occur for 
genetic variants on different (non-homologous) chromosomes, and the degree of LD is partly a 
function of the distance between the loci (see Appendix A for some of the genetic terms used here). 
Depending on the effects of the co-inherited variant, LD can bias the estimates. If our instrument 𝑍 
is in LD with another polymorphic locus that affects only the modifiable risk factor  𝐴, the IV 
estimates remain consistent. However, if 𝑍 is in LD with a polymorphic locus that directly affects the 
outcome 𝑆, Assumption 3 is violated and the estimate will be biased and inconsistent. Relatedly, 
there is the situation of pleiotropy, where one genetic variant has multiple functions. The case is 
similar to that of LD, and will invalidate the IV approach if the pleiotropic effect influences the 
outcomes 𝑆 directly, but not if it affects only other characteristics that are unrelated to the outcome 
of interest.  
Fourth, a biological process that may bias causal estimates in Mendelian randomization studies is 
canalisation. This refers to a situation by which potentially disruptive influences of the risk factor on 
the outcome are buffered by foetal or post-natal developmental processes. For example, if an 
individual has a genetic variant associated with higher blood pressure, their arteries may develop to 
become resistant to the adverse effects of high blood pressure. This is difficult to test for, as the 
genetic variant may still be related to blood pressure, but any adverse health outcomes normally 
caused by higher blood pressure would not occur. Hence, canalisation can alter the association 
between genotype and outcome, without any change in the genotype-risk factor relationship. In 
other words, canalisation results in an indirect ‘effect’ of the genotype on the outcome of interest, 
violating the exclusion restriction.   10 
 
Assumption 4 – Non-zero effect of 𝑍 on 𝐴  
Mendelian randomization can only be used with genetic variants that have been robustly shown to 
affect the risk factor of interest. This means it relies on prior knowledge about the association 
between genotype and phenotype, as shown in a large number of independent studies. This latter 
point is especially important, as many initial genetic associations fail to replicate (Colhoun, McKeigue 
and Davey Smith, 2003). Without a robust and consistent population association, even if a significant 
sample correlation exists, Assumption 4 may be violated. Any correlation may simply be due to 
factors such as biased measurement (in genotype or phenotype) or chance.  
However, even if a suitable and robust genetic instrument is available, it may explain little of the 
variation in observed phenotype. A weak association could result in a biased IV estimate and has 
implications for statistical power. If the alleles shift the distribution of 𝐴 by a very small amount, the 
effect of 𝐴 on 𝑆 is identified only by this small difference in mean treatment, emphasizing the need 
for very large sample sizes, especially when the average causal effect of the risk factor on the 
outcome could be small. This, of course, is not a problem specific to Mendelian randomization, but 
refers to a more general problem of weak instruments, often encountered in IV studies (e.g. Angrist 
and Krueger, 1991).  
 
Assumption 5 – Monotonicity 
With random allocation of genetic variants and the fact that individuals do not know their 
genotypes, we assume that an individual who carries the risk allele is at least as heavy as the same 
individual, had she not carried the risk allele, satisfying the monotonicity Assumption 5. As this relies 
on knowing each individual’s counterfactual adiposity, this remains an assumption. The literature 
only tells us that, at a group or population level, those who possess the genetic variant are heavier 
than those who do not. The monotonicity assumption could for example be violated in the presence 
of gene-environment interactions (i.e. when the effect of the environment on weight differs 
depending on the individuals’ genetic predisposition, or when individuals’ genetic predispositions 
are expressed differently in different environments).  
 
2.4   The Role of Covariates in Mendelian Randomization Experiments 
There is a large literature on the use of covariates in IV. Social and economics applications of IV 
generally include a wide set of control variables; the main motivation being that the conditional   11 
independence and exclusion restriction are more likely to be valid. A second reason for including 
covariates in many social and economics applications of IV is that it may reduce the variability in the 
dependent variable, leading to more precise estimates. Most IV models that include covariates use 
parametric specifications, but a causal interpretation of the IV estimate usually requires the 
assumptions of additive separability and constant treatment effects to hold. There are ways to relax 
these assumptions though, using non-parametric specifications (see e.g. Fröhlich (2007) for a 
review). 
The situation is somewhat different, however, in RCTs/encouragement designs, and Mendelian 
randomization studies. When covariates enter the assignment mechanism in RCTs/encouragement 
designs, such as when randomization takes place within certain strata, these covariates should be 
controlled for, relying on the conditional independence assumption. The inclusion of further baseline 
covariates may in addition increase the precision of the estimates. In Mendelian randomization 
studies however,  there are no baseline covariates. In addition, as covariates do not enter the 
assignment mechanism,  assignment is independent of covariates, and we can  rely on the 
(unconditional) independence assumption. Only in the presence of population stratification should 
the analyses be done within  population subgroups, or should we be adjusting for principal 
components from genome wide data that  function as ancestry markers,  i.e.  relying on the 
conditional independence assumption. Therefore, conditioning on covariates in not necessary in 
Mendelian randomization experiments. 
Although one may choose to adjust for covariates to increase precision, this raises the issue of which 
covariates to include in a Mendelian randomization study, as any characteristic is, in principle, a 
post-treatment variable with respect to the instrument, and – with that – may be affected by the 
instrument. If the instrumented risk factor has multiple causal effects, or if the outcome of interest 
has a causal effect of its own, adjusting for such post-treatment variables may  lead to biased 
estimates of the causal effect of interest.  Indeed, we should not control for any ‘downstream’ 
behavioural covariates that are potentially affected by the treatment or outcome. Hence, although 
our application is in the context of a social study, we do not control for covariates, though we report 
the estimates that adjust for covariates in the text. Under the independence assumption, and in a 
situation where the instrumented risk factor and outcome do not (directly or indirectly) affect these 
covariates, the unadjusted and adjusted IV estimates should be similar, though the latter may be 
more precise. 
 
2.5   Testing the Exclusion Restriction   12 
There is no direct test for the validity of the exclusion restriction (Assumption 3). In other words, its 
validity will never be known with complete certainty and can only be examined indirectly or falsified 
by the data. To this end, however, Mendelian Randomization is no different from any other (non-
genetic) IV study; the exclusion restriction always remains an assumption. Similar to other IV studies 
that use multiple instruments however, Mendelian randomization allows for potential violations 
through pleiotropy or LD (though not necessarily canalisation) to be tested when data is available on 
a large number of genetic instruments. More specifically, if multiple IV models - each using different 
combinations of these variants - predict the same causal effect, this is very unlikely to be due to 
some common pleiotropy or LD across the different sets of variants, assuming that the different 
variants are located on different chromosomes and affect the trait via different pathways (Davey 
Smith, 2011; Palmer et al., 2011). However, obtaining different causal effects with different 
combinations of variants does not necessarily point to a violation of the exclusion restriction, as 
variability in treatment effects may occur due to different compliant subpopulations for the different 
instrument sets (also known as different Local Average Treatment Effects, or LATEs). 
In a constant effects model, one can indirectly test whether the exclusion restriction holds using an 
‘over-identification’  test, provided there are more instruments than ‘endogenous’  variables  (i.e. 
variables confounded by unobserved factors).  Note, however, that this is not a test that the 
instruments are indeed valid. A problem with the over-identification test is that it has low power, 
especially when the underlying IV estimates are imprecise. In our framework of heterogeneous 
treatment effects however, over-identification tests are inappropriate, even when the underlying 
estimates are precise, as a rejection of the test need not imply a violation of the exclusion 
restriction. As discussed above, it may point to treatment effect heterogeneity, as different valid 
instruments for the same causal effect may estimate different parameters, with the final IV estimate 
being a weighted average of the different treatment effects (Angrist, Graddy and Imbens, 2000; 
Angrist and Pischke, 2009). Hence, although we report the test below, we cannot necessarily 
interpret it in a heterogeneous treatment effects framework.  
Note that, although canalisation refers to a violation of the exclusion restriction, it cannot 
necessarily  be tested (either directly or indirectly) using over-identification tests. Similar to the 
above,  a rejection of the test cannot distinguish between treatment effect heterogeneity  and 
canalisation. In fact, there is no (clear) way of testing or correcting for canalisation. However, for the 
complex traits that are largely of interest as causal risk factors in Mendelian randomization studies, 
there is no evidence that canalisation occurs in humans (Davey Smith and Ebrahim, 2003). 
   13 
2.6   The Genetic Variants in our Empirical Application 
We use two SNPs that have been consistently shown to relate to Body Mass Index (BMI, defined as 
weight in kg divided by height in metres squared) and adiposity in children and adults. Using a total 
of 38,759 individuals aged between 7 and 80 from 13 different cohorts of European ancestry, 
Frayling et al. (2007) explore the association between FTO and BMI, fat mass, the risk of being 
overweight and the risk of being obese. They find a positive association between the risk allele (A) 
and all measures of adiposity for individuals in all cohorts, in all countries, of all ages and of both 
sexes, with no difference between males and females. They show that FTO is specifically associated 
with fat mass, with weaker associations with lean mass. In addition, there is no association between 
FTO and birth weight, or FTO and height, suggesting that the relationship with BMI is largely driven 
by individuals’ adiposity. They find that each copy of the risk allele is associated with an average 
increase in BMI of 0.2 units at age 7, to 0.4 units at age 11. For the average age-specific height, this 
refers to a weight increase of 0.3 and 0.9 kg respectively. As the genetic model for FTO is additive, 
meaning that each risk allele affects the phenotype by a similar amount, 11-year-olds who are 
homozygous for the rare allele (AA) are on average 1.8 kg heavier compared to those carrying no 
rare alleles. Using age-specific growth charts of weight, this corresponds to an increase from the 
median to the 58
th percentile. However, there is much variation around this mean effect; the R
2 of a 
(linear) regression of adiposity on FTO is less than 1%.  
Several different SNPs near MC4R have been associated with adiposity. We use the SNP identified by 
Loos et al. (2008).  In addition to replicating the FTO  findings, they find a positive relationship 
between rare allele (C) of MC4R  and adiposity in genome-wide association data from 16,876 
individuals and confirm this relationship in an additional 60,352 adults and 5,988 children. They find 
no differences by gender, and no effects on birth weight or children’s height, again suggesting the 
association is mediated largely through an effect on adiposity. The genetic model for MC4R  is 
dominant, meaning that the presence of any risk allele – either one or two – is associated with a 
similar increase in adiposity (Timpson et al., 2009). The findings on both FTO and MC4R have since 
been replicated in a vast number of other studies (see e.g. Hinney et al., 2007; Hunt et al., 2008; 
Willer et al., 2009; Thorleifsson et al., 2009; Meyre et al., 2009; Speliotes et al., 2010).  
Our specific choice of genetic variants can be related to the assumptions for suitable use of genetic 
variants  as instruments discussed in Section 2.1 and 2.3.  First,  population stratification  due to 
ethnicity may violate the independence assumption, as FTO-allele frequencies are known to vary by 
ethnic group (Frayling et al., 2007). However, it is not likely to be a problem here, as our cohort is 
recruited from a specific geographically defined region with a predominantly white population. In 
addition, our analysis only includes children whose mother describes herself and the child’s father as   14 
white. 
Second, note that those who carry the rare allele of FTO and/or MC4R do not all become obese; the 
variants increase the average body weight by a modest amount. Hence, it is unlikely to observe any 
strong (parental) responses to increased body weight, such as changing children’s diets.  
Third, we rely on the theory of random allocation of genetic variants (independence) and on the 
empirical evidence that shows that genetic variants are  unlikely to be related to unmeasured 
confounders (exclusion). Pleiotropy or LD would bias the IV estimates if the variant affects the 
outcome directly or if the linkage is with another variant that directly affects educational 
attainment.  
Fourth, the possible mechanisms through which FTO and MC4R affect adiposity are increasingly 
studied in the medical literature. Although this work is ongoing, there is substantial evidence that 
the variants are associated with an increased consumption of fat and energy (see e.g. Timpson et al., 
2008; Cecil et al., 2008). The literature suggests that the SNPs increase food intake due to diminished 
satiety (Wardle et al., 2008), rather than through pathways that affect our schooling outcome of 
interest, suggesting that Assumption 3 is satisfied. 
Fifth, as noted above, the biological mechanisms through which FTO and MC4R affect adiposity are 
unknown, but the evidence to date suggests that size at birth is not affected by these variants. 
Therefore, canalisation during the foetal period is unlikely to be a problem. 
Sixth, the prior findings of robust associations between the genetic variants and individual adiposity 
justify their use as instruments (Assumption 4). Each FTO risk allele leads to an average increase of 
0.9 kg; carrying one or two MC4R  risk alleles is related to an average increase of 0.6 kg. As 
mentioned above however, with much variation around this mean effect, our two genetic variants 
explain little of the total variation in adiposity: R
2 < 1%. Using the standard statistical tests, we will 
examine the strength of our instruments in the application below.  
Finally, as monotonicity (Assumption 5) can be violated by gene-environment interactions, we 
examine this indirectly, testing whether the association between adiposity, FTO and MC4R differs by 
‘environment’, as defined by gender, social class, mother’s education, and income. The results 
(available from the authors  on request) show no significant differences, suggesting that these 
interactions do not play an important role for the genetic variants used here.  
 
2.7   Main Advantages Relative to Previous Studies that use Genetic Variants 
The existing economics literature includes three studies that exploit genetic variation to identify the   15 
effects of BMI on economic outcomes. Ding et al. (2009) examine the effects of several health 
conditions, one of which is BMI, on adolescent’s academic achievement. Their IV results show large 
and significant negative effects on female’s Grade Point Average (GPA), but not for males. GPAs for 
obese girls are on average 0.8 points lower than those for non-obese girls. They use four genetic 
variants as instrumental variables: the dopamine transporter (DAT1), the dopamine D2 receptor 
(DRD2), tryptophan hydroxylase (TPH) and cytochrome P4502B6 (CYP2B6).  Fletcher and Lehrer 
(2011) take a similar approach to Ding et al. (2009), but use a different dataset (the Add Health data) 
to exploit within-family genetic inheritance. They find no evidence that obesity affects academic 
achievement. In addition to DAT1 and DRD2, their instruments include the dopamine D4 receptor 
(DRD4), the serotonin transporter (5HTT), monoamine oxidase (MAOA) and cytochrome P4502A6 
(CYP2A6). Finally, Norton and Han (2008) examine the effects of BMI on labour market outcomes 
using DAT1 and DRD4 as instrumental variables for BMI and find no evidence of a causal association.  
The discussion in Section 2.3 above highlights the importance of the choice of genetic variants in 
Mendelian randomization experiments. Although the validity of the exclusion restriction can never 
be tested directly, it is very unlikely that genes related to neurotransmitters, such as those used in 
the three studies described above,  are valid instruments. The inherent problem is that 
neurotransmitters are implicated in many different neurological processes. Hence, it is difficult to 
argue that they can be used as valid instruments for one specific risk factor without being associated 
with others that could plausibly influence the outcome of interest (Cawley et al., 2011; von Hinke 
Kessler Scholder et al., 2011). 
In addition, Assumption 4 states that consistent and robust associations should have been shown 
between the genotype and phenotype in a large number of independent studies. The three studies 
cited above do not appear to have taken this approach (Lawlor, Windmeijer and Davey Smith, 2008). 
Rather than basing their selection of genetic variants on associations that are robustly shown in the 
literature, their choice of instruments seems to be data-derived: using either forward stepwise 
estimation (Ding et al., 2009) or selecting those SNPs that have nominally statistically significant 
sample correlations in the first stage (Fletcher and Lehrer, 2011). In fact, both Ding et al. (2009) and 
Fletcher and Lehrer (2011) acknowledge that there is weak and inconsistent evidence in the medical 
literature, based on very small unrepresentative clinical samples, of the association between their 
genetic variants and health status or behaviours. Indeed, the IV strategy is invalid when relying only 
on these sample associations, as the absence of a robust population association violates Assumption 
4. Norton and Han (2008) base their selection of SNPs on a study by Guo et al. (2006), who argue 
that there is a negative association between the D4.7/D4.7 genotype of DRD4 and obesity. This 
relationship, however, has not been replicated in other independent studies (see for example   16 
Hinney et al. (1999), or Fletcher and Lehrer (2011) who find an insignificant but positive association).  
In addition, these studies are unable to replicate various associations they note are reported in the 
literature. For example, Ding et al. (2009) find no association between the number of 10-repeat 
alleles of the DAT1 gene and obesity, whilst they note the literature reports a positive relationship, 
and Norton and Han (2008) find a negative correlation. Fletcher and Lehrer (2011) fail to show any 
correlation between the A1A1 variant of DRD2 and obesity. But given that the evidence of a robust 
association for these variants is lacking, this is not surprising (Lawlor, Windmeijer and Davey Smith, 
2008). Furthermore, Norton and Han (2008) argue that the effects of the genetic variants differ by 
gender, while Patsopoulos et al. (2007) note that most claims of gender differences are spurious. 
Finally, Norton and Han (2008) use several variants as additional controls rather than instruments, as 
they fail the over-identification tests (SLC6A4, MAOA, DRD2 and CYP2A6). Fletcher and Lehrer (2011) 
and Ding et al. (2009) use several of these as their instruments.  
 
3.   Data 
Our data are from a cohort of children born in one geographic area (Avon) of England. Women 
eligible for enrolment in the population-based Avon Longitudinal Study of Parents and Children 
(ALSPAC) had an  expected delivery date between 1 April 1991 and 31 December 1992. 
Approximately 85% of these mothers enrolled, leading to about 14,000 pregnancies. The Avon area 
has approximately 1 million inhabitants and is broadly representative of the UK as a whole, though 
slightly more affluent than the general population (Golding et al. 2001; see www.bristol.ac.uk/alspac 
for more a detailed description of the representativeness of the sample, its enrolment, and response 
rates). Detailed information on the study children and their families has been collected using a 
variety of sources, including self-completed questionnaires, data extraction from medical and 
educational records, in-depth interviews, and biological samples. Note however, that ALSPAC is a 
cohort; there is no systematic data collection on siblings that we can exploit. 
A total of 12,620 children survived past the age of 1 and returned at least one questionnaire. Of 
these, 642 were excluded because either their mother or father is of non-white ethnic origin, leaving 
11,978 potential participants. Our sample selection process is as follows. First, we select those 
children for whom we observe their genotypes, leaving us with 7,368 children. Second, we drop 
children with missing data on fat mass. Children were invited to attend research clinics, where their 
anthropometric measures were recorded. As not all children attended these clinics, our sample sizes 
reduce to just over 4,500. We further restrict the sample to those children for whom we observe 
their educational outcomes, leading to a final sample size of 3,729 children. T-tests of mean equality   17 
show the final sample to be slightly wealthier than the original ALSPAC sample, with mothers being 
somewhat older and having fewer mental health problems. The probability of being in the final 
sample however, is unrelated to FTO and MC4R, suggesting that sample selection is unrelated to the 
genotypes used here.  
 
3.1   Measures of Academic Achievement 
Our main outcome measure is the child’s Key Stage 3 (KS3) score. The KS3 exam is a nationally set 
exam, taken by all 14-year-olds in English state schools. This measure of children’s performance is 
therefore objective and comparable across all children. Children’s scores for three subjects (English, 
maths and science) are obtained from the National Pupil Database, a census of all pupils in England 
within the state school system, which is matched into ALSPAC. We use an average score for the 
three subjects, standardised on the full sample of children for whom data is available, with mean 
100 and standard deviation 10.  
 
3.2   Measures of Child Adiposity and the Genetic Variants 
Our main measure for child adiposity is the child’s body fat mass (adjusted for age in months, height 
and height squared), as measured by a dual-energy X-ray absorptiometry scan (DXA) at age 11. This 
method scans the whole body, dividing it into body fat, lean tissue mass, and bone density. We 
standardise fat mass on the full sample of children for whom data are available, with mean 100 and 
standard deviation 10. For the genetic variants, we use two SNPs that have been consistently found 
to relate to weight: FTO (rs9939609) and MC4R (rs17782313; the rs-number is an identification tag 
that uniquely positions the polymorphism in the genome). Due to the nature of the association 
between MC4R and adiposity (a dominant genetic model), we group individuals who carry one or 
more risk alleles (C) together. Hence, we observe children in two groups based on their genotype: TT 
vs. CT/CC. FTO is specified as having three categories: no risk alleles (homozygous TT), one risk allele 
(heterozygous AT) and two risk alleles (homozygous AA).  
 
3.3   Descriptive Statistics 
As discussed in section 2.1, we observe six mutually exclusive instrumental variables, as defined by 
the combination of the number of rare alleles in FTO  and  MC4R.  We begin by showing their 
frequencies. Without loss of generality, we order  the instruments  by  their mean fat mass, as 
presented in Table 1. Hence, our instrument contains the following combinations of the genetic   18 
variants: (𝐹𝑇𝑂,𝑀𝐶4𝑅) ∈ {(𝑇𝑇,𝑇𝑇),  (𝑇𝑇,𝐶𝑇/𝐶𝐶), (𝑇𝐴,𝑇𝑇), (𝑇𝐴,𝐶𝑇/𝐶𝐶), (𝐴𝐴,𝑇𝑇),  (𝐴𝐴,𝐶𝑇/𝐶𝐶)}. 
We refer to these as 𝑍 = 1,…,6 respectively. Table 1 shows that the first group defined by the 
instrument (𝑍 = 1, i.e. those homozygous for the common allele of both FTO and MC4R) has a mean 
(standardised) adiposity of 98.4, with the last group (𝑍 = 6) having a mean (standardised) adiposity 
of 102.4. 
We can further examine the adiposity distribution for individuals within each of the six groups by 
plotting  the empirical fat mass distribution functions (as in Angrist, Graddy and Imbens, 2000). 
Figure 1 shows large differences, with the adiposity distribution of the (𝐴𝐴,𝐶𝑇/𝐶𝐶) group (i.e. 
𝑍 = 6; those homozygous for the rare allele of FTO, and heterozygous or homozygous for the rare 
allele of MC4R) lying to the right of all others for most values of adiposity.  
Figure 2 presents the differences between these distribution functions, plotting the unnormalised 
weight functions. As discussed in section 2.1, the IV approach estimates the coefficient of interest (2) 
as the average causal derivative for the shift in adiposity at each value of the instrument. We 
therefore show the weight functions for those combinations of 𝑍 used in the final IV estimate.  
The figures show slightly different weight functions for different instrument values. In the left figure 
for example, taking the difference between the distribution function of 𝑍 = 1 and  𝑍 = 2, more 
weight is given to the higher end of the fat mass distribution, whereas the difference between 𝑍 = 2 
and  𝑍 = 3  gives more weight to the lower end of the adiposity distribution. The other weight 
functions, shown in the figure on the right, show similar weights for the different instrument values, 
mainly affecting the middle of the adiposity distribution. The smallest weights in the IV estimation 
are given for the difference between the distribution functions of 𝑍 = 4  vs.  𝑍 = 5, the largest 
weights are for 𝑍 = 5 vs. 𝑍 = 6. 
Finally, Appendix B  indirectly tests the independence assumption by exploring whether the 
distribution of covariates is the same in different groups defined by the value of the instrument. 
Although there are no actual pre-treatment variables with respect to the instrument, and significant 
differences do not necessarily indicate violation of independence (see also section 2.3), we find no 
evidence of systematic differences for the different covariates, providing at least suggestive 
evidence of randomization of the genetic variants. 
 
4.   Results 
Table 2 presents the results. Column 1 shows the association between the KS3 score at age 14 and 
fat mass at age 11. This estimate is similar to the adiposity-coefficient of an OLS regression of KS3 on   19 
fat mass. The (unadjusted) relationship between fat mass and educational attainment is negative, 
with a one standard deviation increase in fat mass associated with a 0.1 standard deviation decrease 
in test scores.  
Column 2 presents the first-stage regression results, showing a strong positive relationship between 
the different instrument values and child fat mass. The estimates increase with the instrument 
values, as expected by construction of the instrument. The strength of the relationship between the 
instruments and fat mass is shown by the first stage F-statistic; with a value of 9.4, it is relatively 
weak. However, if we were to use 𝑍 as one instrument, rather than five separate dummies, the F-
statistic rises to over 45, confirming the strength of our genetic variants. 
The second stage IV results are presented in column 3, showing no effects of fat mass on educational 
performance. Although the IV estimate is of similar magnitude but opposite sign to that in column 1, 
the large standard errors preclude us from rejecting the null of no effect. However, with a p-value of 
0.053 for the Hausman test, there is some support for the IV estimate as opposed to the OLS 
estimate, though any such judgement should be based on a synthesis of all the evidence, rather than 
on this one test alone. Appendix C presents the IV estimates that distinguish between the different 
values of the instrument 𝑍 that are shown in Table 1. As discussed in section 2.1, the final IV 
estimate in Table 2, column 3,  is a weighted average of these separate regressions.  The over-
identification (Hansen J) test does not reject the null although, as discussed above, it is difficult to 
interpret this test in a heterogeneous treatment effects framework. Even when we control for the 
set of background characteristics mentioned in Appendix B, the IV estimate remains very similar to 
the unadjusted results (0.111 vs. 0.140 in Table 2), with a slightly smaller standard error (0.111 vs. 
0.131), though the p-value remains large (0.315 vs. 0.282). 
 
5.   Conclusion and Discussion 
The increasing availability of biomedical data, in combination with a growing medical literature on 
the effects of carrying specific genetic variants, introduces a different approach to the examination 
of certain risk factors on different  outcomes. This paper discusses the method of instrumental 
variables using Mendelian randomization, and relates this to the statistical framework of potential 
outcomes. 
We discuss the specific conditions that need to be met for genetic variants to be used as 
instruments, and relate these to the statistical assumptions necessary for identification of the 
average causal response using instrumental variables. These conditions have not been well defined 
in the current social science literature, but the increasing availability of biomedical data makes   20 
understanding of these conditions crucial to the successful use of genotypes as instruments for 
modifiable risk factors. To clearly communicate best practice in genetic epidemiology to a wider 
social science audience, we review these conditions in the context of an empirical social science 
application. Specifically, we examine whether child adiposity causally affects academic achievement, 
using recently identified genetic variants as instrumental variables for adiposity. 
We argue that these variants are the best current candidates for use as genetic markers: they have 
been shown to be associated with adiposity in large population samples and we argue that they are 
likely to meet the conditions required for suitable instruments. We also use direct measures of body 
fat mass, rather than the generally used BMI. OLS shows that leaner children perform better in 
school tests compared to their more adipose counterparts. Our genetic IV analysis, however, shows 
no evidence that children’s fat mass affects their academic performance, although the estimates are 
imprecise. Based on our robust IV approach though, we conclude that adiposity is not a major 
determinant of educational outcomes. 
Our discussion  of the conditions for the suitability of genetic variants as instruments and our 
application raise a more general issue of the use of genetic variants as instrumental variables. In our 
case, while our instruments are not overly weak in a statistical sense, their effects may be too small 
to impact on the possible pathways to academic performance. In other words, a two kilogram 
increase in adiposity may not lead to a large drop in self-esteem or an increase in absenteeism. To 
that end, it is perhaps not surprising that we do not find a significant effect on academic 
performance. That said, FTO is the strongest adiposity-marker yet identified. It is relatively unlikely 
that common variants will be found with larger adiposity-effects, as those with larger effects tend to 
be discovered before smaller ones (though rare variants with stronger effects may be identified).  
This illustrates the more general question of whether genetic variants are powerful enough to 
identify causal effects in studies examining economics or social science outcomes. The answer to this 
question will depend on the variant, the risk factor and the outcome of interest. With a rapidly 
growing medical literature on the effects of carrying specific genetic variants, one option is to wait 
for more variants to be identified and to combine these into one or more instrumental variables, 
such as a (weighted) count of the number of risk alleles (see e.g. von Hinke Kessler Scholder et al., 
2010). This could increase the explained phenotypic variation and with that, the precision of the 
estimates. But as noted, in the case of adiposity - and other physical attributes that economists have 
been interested in, such as height - any additional variants are likely to have even smaller effects 
than those already identified.  
In conclusion, we argue that genetic instruments need to be used with care. Their appropriate use   21 
requires that several conditions, which have not hitherto been spelt out in the social science 
literature, are met. But even if these conditions are met, the sample sizes in data sets that contain 
both genetic markers and outcomes of interest to social scientists  may be too small to obtain 
definitive results. Indeed, even with almost 4000 observations, our standard errors are relatively 
large. With a rapid increase in the number of genome wide association studies being done, and with 
a decrease in their costs  however, this may change.  With that, we believe that Mendelian 
randomization presents a promising approach to estimate the causal effect of a modifiable risk 
factor on one or more outcomes of interest, though we reiterate that this hinges on the correct 
selection of genotypes as instruments for risk factors.   22 
Appendix A: A Brief Introduction to Genetics 
Each cell in the human body contains a nucleus in which most DNA (99.9995%) is kept. DNA is stored 
in structures called chromosomes, where each chromosome contains a single continuous piece of 
DNA. All cells in the human body apart from gametes (i.e. germ cells) contain 46 chromosomes, 
organised into 23 chromosome pairs: one copy of chromosome 1-22 from each parent, plus an X-
chromosome from the mother and either an X or a Y chromosome from the father.  
Locations (or loci) where DNA varies between people are called polymorphisms. The most commonly 
studied form of polymorphism is a Single  Nucleotide Polymorphism (SNP): a single base-pair 
variation in a DNA locus. As chromosomes come in pairs, humans have two base-pairs at each locus, 
called alleles. These alleles can either be the same or different. The term genotype is used to 
describe the specific set of alleles inherited at a particular chromosome locus. For example, 
individuals can have one of three genotypes of FTO: they can be homozygous for the common allele 
(TT), heterozygous (AT), and homozygous for the rare allele of FTO (AA). The visible or measurable 
effect of a particular genotype is called the phenotype.  
The phenotype we examine is fat mass. Many studies have examined the heritability of adiposity, 
where heritability is defined as the proportion of the total variance that is explained by genetic 
factors; most commonly calculated from twin studies by comparing intra-pair correlations for a 
characteristic in monozygotic twins with that in dizygotic twins. These studies generally report large 
heritability estimates: between 0.4 and 0.7. A high heritability however, does not imply that any 
individual genetic variant has large phenotypic effects. For example, there are many different SNPs 
that affect human weight, though all with small effects: so-called ‘polygenes’. Together, these 
variants may have a large phenotypic effect. 
Until recently, researchers mainly used a ‘candidate gene approach’ to examine associations 
between individual genetic variants and a phenotype. This approach consists of testing a specific 
hypothesis: based on biological knowledge, researchers examine the association between one 
particular variant (the candidate genetic variant) and a phenotype. These studies produced many 
false-positive findings (Colhoun et al., 2003) and were inefficient. Genome wide association studies 
(GWAS) followed, genotyping 500,000 to over 1,000,000 SNPs in one go and relating all SNPs to the 
phenotype of interest in a hypothesis-free way. Stringent criteria are used for GWAS p-values to take 
account of this hypothesis-free approach. Studies are either two-stage studies, where one or more 
GWAS is performed, after which the small number of SNPs that reach GWAS levels of statistical 
significance are typed in other independent samples to examine the robustness. Alternatively, 
studies consist of a number of independent GWAS containing a large total sample size, where only 
those SNPs that have consistent associations across all studies are interpreted as robust.     23 
Appendix B: Indirect Test of Independence of Covariates and Genetic Variants 
Table B1 presents the coefficients (standard errors) of a regression of the covariate presented in the 
first column on the five values of the instrument (𝑍 = 2,3,4,5,6). The final column shows the p-value 
of an F-statistic testing whether the coefficients jointly equal zero. With random assignment of the 
genetic variants, there should be no systematic variation in the covariates by genotype. Although 
some p-values are lower than the commonly used 0.01 or 0.05, we find no evidence of systematic 
differences for the different covariates, providing at least suggestive evidence of randomization of 
genetic variants. 
 
Table B1: An indirect test of independence: regressing the covariate on the instrument-dummies. 
   
𝑍 = 2 
 
𝑍 = 3 
 
𝑍 = 4 
 
𝑍 = 5 
 
𝑍 = 6 
p-value of F-test: 
instrument-coefficients 
jointly equal to zero 
Girl  -0.043  -0.024  -0.010  0.062*  0.010  0.045 
  (0.03)  (0.02)  (0.03)  (0.032)  (0.037)   
Birth weight (g)  -38.58  5.43  -17.79  8.76  -15.48  0.685 
  (30.70)  (25.90)  (27.12)  (35.60)  (40.96)   
Age at KS3 (in months)  0.22  0.09  0.14  0.02  0.38  0.737 
  (0.20)  (0.18)  (0.19)  (0.24)  (0.27)   
Ln(income)  -0.02  0.02  -0.01  0.02  0.01  0.716 
  (0.02)  (0.02)  (0.02)  (0.03)  (0.04)   
Mother’s education  0.05  0.04  0.02  0.05  -0.02  0.779 
  (0.05)  (0.04)  (0.05)  (0.06)  (0.06)   
Raised by natural father  -0.01  0.01  -0.01  0.00  -0.00  0.600 
  (0.01)  (0.01)  (0.01)  (0.02)  (0.02)   
Social class at birth  -0.06  -0.06  -0.03  -0.18**  -0.19**  0.157 
  (0.07)  (0.06)  (0.07)  (0.08)  (0.09)   
Mum works part-time  0.00  -0.01  0.02  0.01  -0.02  0.901 
  (0.03)  (0.02)  (0.03)  (0.03)  (0.04)   
Mum works full-time  0.00  0.00  -0.02  0.02  -0.02  0.210 
  (0.02)  (0.01)  (0.01)  (0.02)  (0.02)   
Partner employed  -0.02  0.01  -0.01  -0.01  -0.02  0.618 
  (0.02)  (0.02)  (0.02)  (0.02)  (0.03)   
Index of Multiple   -0.93  0.59  0.06  0.26  0.55  0.437 
      Deprivation  (0.75)  (0.67)  (0.70)  (0.90)  (1.01)   
Alcohol during pregnancy  -0.02  0.04  0.01  -0.02  0.04  0.161 
  (0.03)  (0.02)  (0.03)  (0.03)  (0.04)   
Smoke during pregnancy   0.01  0.01  0.01  -0.03  -0.01  0.615 
  (0.02)  (0.02)  (0.02)  (0.02)  (0.03)   
Breastfeeding  0.10  0.06  0.12**  -0.03  0.22**  0.053 
  (0.07)  (0.06)  (0.06)  (0.08)  (0.09)   
Mother’s age at birth  -0.01  0.03  0.01  -0.03  -0.13*  0.265 
     (0.05)  (0.04)  (0.05)  (0.06)  (0.06)   
Notes: The p-value in the last column corresponds to an F-test of the coefficients on the five instrumental variables jointly 
equalling zero. * p<0.1; ** p<0.05; *** p<0.01; Ln(income) is measured when the child is aged 3-4 as is in 1995 prices; 
mother’s educational level is a categorical variable with four values (less than ordinary (O) level, O-level, advanced (A) 
level, and university degree); social class is measured using the standard UK classification of class based on occupation 
(professional (I), managerial and technical (II), non-manual skilled (IIInm), manual skilled (IIIm), semi-skilled (IV) and 
unskilled (V)); the Index of Multiple Deprivation (IMD) is a measure of local area deprivation, referring to areas containing 
about 8000 persons; breastfeeding is a categorical variable (never, <1 month, 1-3 months and 3+ months). 
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Appendix C: IV Estimation using Different Instrument Sets  
Table C1 presents the IV results using different instrument sets. As discussed in section 2.1, we 
recode our multiple multi-valued instruments to a set of mutually exclusive dummy variables, 
resulting in six binary instrumental variables. Here we show the IV estimates using each of these 
distinct values.  
Column (1) replicates the IV estimate from Table 2, using the five dummies simultaneously. Column 
2 shows the IV estimate when using only those observations with the instrument 𝑍 equal to 1 or 2. 
Column 3 includes those with 𝑍 = 2 or 3; column 4 uses those with 𝑍 = 3 or 4; column 5 includes 
those with 𝑍 = 4 or 5; and column 6 uses those with 𝑍 = 5 or 6. Finally, column 7 shows the IV 
estimate using a linear specification of the instrument. 
This shows that, for low values of the instrument (𝑍 = 1,2,3), the IV estimate is negative, though 
always with large confidence intervals. Higher values of 𝑍 give positive estimates, with a very large 
estimate for 𝑍 ∈ {4,5} in column 5, but it is very imprecisely estimated. Note also that, as shown in 
Figure 2, this estimate gets the lowest weights over the distribution of fat mass, and hence the final 
IV estimate in Table 2 is not driven by this large estimate. In contrast, the largest weights shown in 
Figure 2 are for the specification with 𝑍 ∈ {5,6} (column 6 below), which is indeed closest to our 
final IV estimate. 
 
Table C1.  IV estimates of the average response in standardised KS3 to a 1 standard deviation change in fat 
mass, different instrument sets 
  (1)    (2)  (3)  (4)  (5)  (6)  (7) 
Instruments:  Full sample, 
five 
instruments 
   
𝑍 ∈ {1,2}  
 
𝑍 ∈ {2,3}  
 
𝑍 ∈ {3,4}  
 
𝑍 ∈ {4,5}  
 




                 
Fat Mass  0.140    -0.204  -0.107  0.131  1.876  0.139  0.136 
  p=0.282    p=0.801  p=0.821  p=0.836  p=0.660  p=0.785  p=0.305 
  [-0.12, 0.40]    [-1.79, 1.38]  [-1.03, 0.82]  [-1.11, 1.37]  [-6.48, 10.2]  [-0.86, 1.13]  [-0.12, 0.40] 
N  3729    1356  1604  1784  1103  589  3729 
                 
Notes: Column 1 is the specification as in Table 2, column 3: using the five instruments 𝑍 ∈ {2,3,4,5,6}. Column 2 only uses 
(𝑇𝑇,𝑇𝑇) and (𝑇𝐴,𝑇𝑇) (i.e. 𝑍 equalling 1 or 2); Column 3 only uses observations with 𝑍 equalling 2 or 3. Column 4 includes 
those with 𝑍 = 3 or 4; Column 5 includes those with 𝑍 = 4 or 5; Column 6 includes those with 𝑍 = 5 or 6. Column 7 
shows the IV estimate using a linear specification of the instrument. 95% confidence intervals in square brackets; p is p-
value for standard t-ratio. 
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Figure 2: Unnormalised Weight Functions for the Different Instrument Values 
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Table 1: The six values of the instrumental variable 
Z  FTO  MC4R  (FTO, MC4R)  Frequency  Mean fat mass 
1  TT  TT  (TT,TT)  0.208  98.398 
2  TT  CT/CC  (TT,CT/CC)  0.156  98.998 
3  TA  TT  (TA,TT)  0.274  99.963 
4  TA  CT/CC  (TA,CT/CC)  0.204  100.654 
5  AA  TT  (AA,TT)  0.092  100.990 










Table 2. OLS and IV estimates of the average response in standardised KS3  
 
Dependent variable: 
 (1) – OLS 
 
KS3 
 (2) – First stage IV 
 
Fat Mass 
 (3) – Second stage IV 
 
KS3 
  Coeff  p-value  Coeff  p-value  Coeff  p-value 
Fat Mass             
   Estimate and p-value  -0.099  <0.001      0.140  0.282 
   95% confidence interval  [-0.128, -0.070]    [-0.115, 0.396] 
       
Instrument        
   Z=2: (TT,CT/CC)    0.600  0.247   
    [-0.416, 1.616]   
   Z=3: (TA,TT)    1.564  <0.001   
    [0.687, 2.441]   
   Z=4: (TA,CT/CC)    2.256  <0.001   
    [1.301, 3.210]   
   Z=5: (AA,TT)    2.591  <0.001   
    [1.326, 3.857]   
   Z=6: (AA,CT/CC)    3.980  <0.001   
    [2.477, 5.482]   
       
             
       
First stage F-statistic    9.365   
p-value, Hansen J-test      0.631 
p-value, Hausman test      0.053 
R-squared  0.01  0.014   
Number of children  3729  3729  3729 
       
 
 
 
 